| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8214202 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 29 Pages |
Abstract
High E6 gene expression level identifies HPV-positive OPSCC patients with 5-fold greater risk of distant disease recurrence and worse cancer-specific survival. Validation in a multi-institutional prospective clinical trial is required to assess the utility of E6 gene expression as a clinically useful prognostic biomarker.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Shariq S. MD, PhD, Callie MS, Wesley BS, Christopher R. MD, Hiram MD, Wade MD, Douglas R. MD, Brian MD, Rebecca D. MD, James S. MD, Xiaowei PhD,